Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hemophilia A With Inhibitor”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)Study completedNCT03417102
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 60
Not applicableWithdrawnNCT01051544
What this trial is testing

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center
Large-scale testing (Phase 3)UnknownNCT06155955
What this trial is testing

Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A

Who this might be right for
Severe Hemophilia A Without InhibitorJoint Bleed
Chulalongkorn University 15
Post-approval studies (Phase 4)UnknownNCT06320626
What this trial is testing

Pharmacokinetic-guided Dosing of Emicizumab

Who this might be right for
Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia A, Severe+3 more
Kathelijn Fischer 95
Post-approval studies (Phase 4)Study completedNCT00323856
What this trial is testing

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Grifols Biologicals, LLC 51
Not applicableStudy completedNCT04181697
What this trial is testing

HemFitBit, an Observational Study of Physical Activity in People With Moderate and Severe Haemophilia A

Who this might be right for
Hemophilia A Without Inhibitor
Oslo University Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Not applicableStudy completedNCT04165135
What this trial is testing

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

Who this might be right for
Severe Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A
Hoffmann-La Roche 103
Not applicableUnknownNCT01505946
What this trial is testing

Thrombin Generation Assay (TGA) as Predictive Test for Haemostatic. Effectiveness of FVIII Concentrates in Haemophiliac A With Inhibitors

Who this might be right for
Severe Hemophilia A With Inhibitor
Grifols Italia S.p.A 25
Not applicableLooking for participantsNCT05802836
What this trial is testing

Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab

Who this might be right for
Severe Hemophilia ASevere Hemophilia A With InhibitorSevere Hemophilia A Without Inhibitor
Christoph Königs 100
Large-scale testing (Phase 3)Looking for participantsNCT05145127
What this trial is testing

Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Pfizer 245
Not applicableStudy completedNCT00166309
What this trial is testing

The FEIBA NovoSeven Comparative Study

Who this might be right for
Severe Hemophilia A With an Inhibitor
Skane University Hospital 60
Large-scale testing (Phase 3)Study completedNCT03938792
What this trial is testing

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 188
Not applicableLooking for participantsNCT07096349
What this trial is testing

Multidimensional Assessment of Chronic Pain in Severe Haemophilia A

Who this might be right for
Hemophilia A Without Inhibitor
Investigación en Hemofilia y Fisioterapia 109
Large-scale testing (Phase 3)Ended earlyNCT04303559
What this trial is testing

The Hemophilia Inhibitor Prevention Trial

Who this might be right for
Hemophilia A Without Inhibitor
Margaret Ragni 1
Not applicableNot Yet RecruitingNCT07788469
What this trial is testing

Elranatamab for Inhibitor Eradication in Patients With Hemophilia A

Who this might be right for
Hemophilia A With Inhibitors
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableStudy completedNCT01051076
What this trial is testing

Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced)

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center 3
Post-approval studies (Phase 4)Study completedNCT00284193
What this trial is testing

Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII

Who this might be right for
Hemophilia A
Sheba Medical Center 5
Large-scale testing (Phase 3)WithdrawnNCT02196207
What this trial is testing

Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform

Who this might be right for
Severe Hemophilia A
Margaret Ragni
Post-approval studies (Phase 4)Ended earlyNCT00621673
What this trial is testing

Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 1
Next Page